Differences in Quantification of the Metabotropic Glutamate Receptor 5 Across Bipolar Disorder and Major Depressive Disorder
Sophie Holmes, Ruth Asch, Margaret T. Davis, Nicole DellaGioia, Neha Pashankar, Jean‐Dominique Gallezot, Nabeel Nabulsi, David Matuskey, Gerard Sanacora, Richard E. Carson, Hilary P. Blumberg, Irina Esterlis
Topics & Concepts
Metabotropic glutamate receptor 5Major depressive disorderPrefrontal cortexMetabotropic glutamate receptorPsychologyBipolar disorderNeuroscienceInternal medicineMedicineGlutamate receptorPsychiatryCognitionReceptorBipolar Disorder and TreatmentTreatment of Major DepressionNeuroscience and Neuropharmacology Research